Copyright
©The Author(s) 2023.
World J Psychiatry. Jul 19, 2023; 13(7): 453-460
Published online Jul 19, 2023. doi: 10.5498/wjp.v13.i7.453
Published online Jul 19, 2023. doi: 10.5498/wjp.v13.i7.453
Categories | Control group, n = 54 | Research group, n = 60 | χ2/t value | P value |
Sex | 0.069 | 0.793 | ||
Male | 32 (59.26) | 37 (61.67) | ||
Female | 22 (40.74) | 23 (38.33) | ||
Age in yr | 40.07 ± 7.01 | 41.28 ± 8.74 | 0.810 | 0.420 |
Course of the disease in yr | 19.56 ± 7.55 | 18.93 ± 5.83 | 0.501 | 0.617 |
Family medical history | 0.252 | 0.616 | ||
Yes | 6 (11.11) | 5 (8.33) | ||
No | 48 (88.89) | 55 (91.67) | ||
Marital status | 0.381 | 0.537 | ||
Married | 33 (61.11) | 40 (66.67) | ||
Single | 21 (38.89) | 20 (33.33) | ||
Educational level | 1.481 | 0.224 | ||
Below high school | 30 (55.56) | 40 (66.67) | ||
High school and above | 24 (44.44) | 20 (33.33) |
- Citation: Liu JL, Tan ZM, Jiao SJ. Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia. World J Psychiatry 2023; 13(7): 453-460
- URL: https://www.wjgnet.com/2220-3206/full/v13/i7/453.htm
- DOI: https://dx.doi.org/10.5498/wjp.v13.i7.453